Cytori Therapeutics to Provide Update on Breast Reconstruction Commercialization Timeline from the 2nd Annual Stem Cell Summit.SAN DIEGO -- Cytori Therapeutics, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CYTX) (FWB (Fixed Wireless Broadband) See fixed wireless. :XMPA XMPA X-ray Electron Microprobe Analysis XMPA Extensible Media Protection Architecture ) will outline its commercialization strategy for the Celution[TM] System breast reconstruction Breast Reconstruction Definition Breast reconstruction is a series of surgical procedures performed to recreate a breast. Reconstructions are commonly done after one or both breasts are removed as a treatment for breast cancer. product and provide an update on the start of the Celution[TM] System cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease clinical trial Monday, February 12, at 11:35 AM Eastern Standard Time, from the 2nd Annual Stem Cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. Summit. The live audio presentation and slides will be made available from a link in the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of Cytori's website at http://www.cytoritx.com. A replay will be available on the Company's website approximately one hour following the live presentation. The Stem Cell Summit The 2nd Annual Stem Cell Summit, Feb. 12-13, 2007, in San Diego, CA, will be the largest gathering of stem cell company executives, scientists, investors and physicians. The meeting will focus on stem cell products that are on the market or expected to enter the market in the very near future. The agenda includes company and product overviews, the latest clinical stem cell developments, and the first live surgery of a stem-cell-based product in the operating room. The conference is being produced by RRY Publications and Robin Young Consulting Group. The full agenda and registration details are at http://www.stemcellsummit.com. Cytori Therapeutics Cytori Therapeutics is developing and seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery, and many other serious chronic and life threatening conditions. To provide these therapies, physicians remove a small amount of a patient's fat, also known as adipose tissue, and run it through Cytori's Celution[TM] System. This System quickly separates and concentrates stem and regenerative cells from adipose tissue so they may be quickly administered back to the patient about an hour later. This system will dramatically improve the way in which personalized cell-based therapies can be delivered to patients. (www.cytoritx.com) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion